Sobolewska B - Search Results

1

Slit lamps and lenses: a potential source of nosocomial infections?

Sobolewska B, Buhl M, Liese J, Ziemssen F. Sobolewska B, et al. Eye (Lond). 2018 Jun;32(6):1021-1027. doi: 10.1038/s41433-017-0004-0. Epub 2018 Jan 30. Eye (Lond). 2018. PMID: 29379104 Free PMC article.

2

Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?

Ziemssen F, Sobolewska B. Ziemssen F, et al. Among authors: sobolewska b. Drugs Aging. 2011 Nov 1;28(11):853-65. doi: 10.2165/11594720-000000000-00000. Drugs Aging. 2011. PMID: 21970950

3

Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.

Sobolewska B, Grimmel C, Gatsiou A, Sopova K, Klein J, Biedermann T, Stellos K, Ziemssen F. Sobolewska B, et al. Ophthalmologica. 2015;234(4):195-210. doi: 10.1159/000437057. Epub 2015 Aug 21. Ophthalmologica. 2015. PMID: 26305017

4

Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues.

Ziemssen F, Sobolewska B, Deissler H, Deissler H. Ziemssen F, et al. Among authors: sobolewska b. Expert Opin Drug Saf. 2016 Jan;15(1):75-87. doi: 10.1517/14740338.2016.1121232. Epub 2015 Dec 11. Expert Opin Drug Saf. 2016. PMID: 26568279 Review.

5

pH of anti-VEGF agents in the human vitreous: low impact of very different formulations.

Sobolewska B, Heiduschka P, Bartz-Schmidt KU, Ziemssen F. Sobolewska B, et al. Int J Retina Vitreous. 2017 Jun 26;3:22. doi: 10.1186/s40942-017-0075-x. eCollection 2017. Int J Retina Vitreous. 2017. PMID: 28652928 Free PMC article.

6

Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations.

Sobolewska B, Heiduschka P, Bartz-Schmidt KU, Ziemssen F. Sobolewska B, et al. Int J Retina Vitreous. 2017 Oct 16;3:45. doi: 10.1186/s40942-017-0097-4. eCollection 2017. Int J Retina Vitreous. 2017. PMID: 29075516 Free PMC article.

7

Influence of aflibercept on platelet activation profile.

Sobolewska B, Golenko J, Poeschel S, Grimmel C, Gatsiou A, Sopova K, Biedermann T, Schenke-Layland K, Stellos K, Ziemssen F. Sobolewska B, et al. Exp Eye Res. 2018 Oct;175:166-172. doi: 10.1016/j.exer.2018.06.009. Epub 2018 Jun 15. Exp Eye Res. 2018. PMID: 29908884

8

Human Platelets Take up Anti-VEGF Agents.

Sobolewska B, Fehrenbacher B, Münzer P, Kalbacher H, Geue S, Stellos K, Schaller M, Ziemssen F. Sobolewska B, et al. J Ophthalmol. 2021 Jun 14;2021:8811672. doi: 10.1155/2021/8811672. eCollection 2021. J Ophthalmol. 2021. PMID: 34221496 Free PMC article.

9

Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration.

Sobolewska B, Sabsabi M, Ziemssen F. Sobolewska B, et al. Clin Ophthalmol. 2021 Oct 27;15:4317-4326. doi: 10.2147/OPTH.S325763. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34737546 Free PMC article.

10

Brolucizumab and Platelet Activation and Reactivity.

Sobolewska B, Poeschel S, Kalbacher H, Bieber K, Paczulla Stanger AM, Stellos K, Ziemssen F. Sobolewska B, et al. Curr Eye Res. 2025 Jan 6:1-10. doi: 10.1080/02713683.2024.2441245. Online ahead of print. Curr Eye Res. 2025. PMID: 39760267 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters